Concepedia

Xiaoke Shi

XS

Statistics

Publications

10

Citations

318

H-Index

10

Active since

2015

Affiliations

Chengdu Institute of Biology(Current)

Chinese Academy of Sciences

University of Chinese Academy of Sciences

Sichuan University

ShenZhen People’s Hospital

Xiaoke Shi is an author at Chengdu Institute of Biology specializing in pharmacology, cell signaling, and oncology.

Publications per year

2015–2024

10

Publications

10

Halofuginone inhibits colorectal cancer growth through suppression of Akt/mTORC1 signaling and glucose metabolism

Guoqing Chen, Chengfang Tang, Xiaoke Shi et al. · Oncotarget · 2015 · 70 citations · Full text

, , +17

5‐Hydroxytryptamine promotes hepatocellular carcinoma proliferation by influencing β‐catenin

Sarwat Fatima, Xiaoke Shi, Zesi Lin et al. · Molecular Oncology · 2015 · 68 citations · Full text

, , +17

Integrating <i>in situ</i> formation of nanozymes with mesoporous polydopamine for combined chemo, photothermal and hypoxia-overcoming photodynamic therapy

Xiaochun Hu, Yonglin Lu, Xiaoke Shi et al. · Chemical Communications · 2019 · 56 citations

, , +17

A small molecule inhibitor of caspase-1 inhibits NLRP3 inflammasome activation and pyroptosis to alleviate gouty inflammation

Dongyi Cao, Zhonghui Zhang, Run-ze Li et al. · Immunology Letters · 2022 · 29 citations

, , +15

Hexachlorophene, a selective SHP2 inhibitor, suppresses proliferation and metastasis of KRAS-mutant NSCLC cells by inhibiting RAS/MEK/ERK and PI3K/AKT signaling pathways

Naijie Fu, Ruiying Xi, Xiaoke Shi et al. · Toxicology and Applied Pharmacology · 2022 · 21 citations

, , +15

1–5 of 10